1 min read
IDEXX Raises 2026 Outlook After Third-Quarter Revenue Reaches $1.214 Billion
Diluted earnings per share were $4.01, up 18% year over year, as the company lifted its full-year revenue and earnings forecasts.

IDEXX Laboratories raised its 2026 revenue and diluted earnings-per-share forecasts after third-quarter revenue reached $1.214 billion, with reported diluted earnings per share rising 18% from a year earlier.
For the quarter ended Sept. 30, diluted earnings per share were $4.01. IDEXX raised its full-year revenue outlook to $4.741 billion to $4.767 billion and its diluted earnings-per-share forecast to $14.96 to $15.16.
“IDEXX delivered exceptional third quarter results, reflecting strong commercial execution and momentum from our innovation-driven growth strategy,” President and CEO Mike Erickson said.